1. Home
  2. CCEL vs MDBH Comparison

CCEL vs MDBH Comparison

Compare CCEL & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • MDBH
  • Stock Information
  • Founded
  • CCEL 1989
  • MDBH 1997
  • Country
  • CCEL United States
  • MDBH United States
  • Employees
  • CCEL N/A
  • MDBH N/A
  • Industry
  • CCEL Managed Health Care
  • MDBH
  • Sector
  • CCEL Health Care
  • MDBH
  • Exchange
  • CCEL Nasdaq
  • MDBH Nasdaq
  • Market Cap
  • CCEL 39.9M
  • MDBH 42.1M
  • IPO Year
  • CCEL 1997
  • MDBH 2023
  • Fundamental
  • Price
  • CCEL $4.83
  • MDBH $4.72
  • Analyst Decision
  • CCEL Strong Buy
  • MDBH
  • Analyst Count
  • CCEL 1
  • MDBH 0
  • Target Price
  • CCEL $8.50
  • MDBH N/A
  • AVG Volume (30 Days)
  • CCEL 13.2K
  • MDBH 4.5K
  • Earning Date
  • CCEL 07-22-2025
  • MDBH 08-12-2025
  • Dividend Yield
  • CCEL 20.62%
  • MDBH N/A
  • EPS Growth
  • CCEL N/A
  • MDBH N/A
  • EPS
  • CCEL 0.01
  • MDBH 0.84
  • Revenue
  • CCEL $32,102,750.00
  • MDBH $3,574,131.00
  • Revenue This Year
  • CCEL $2.49
  • MDBH N/A
  • Revenue Next Year
  • CCEL $0.95
  • MDBH N/A
  • P/E Ratio
  • CCEL $301.41
  • MDBH $5.36
  • Revenue Growth
  • CCEL 2.33
  • MDBH N/A
  • 52 Week Low
  • CCEL $4.75
  • MDBH $3.61
  • 52 Week High
  • CCEL $9.43
  • MDBH $12.00
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 40.85
  • MDBH 56.60
  • Support Level
  • CCEL $4.80
  • MDBH $4.49
  • Resistance Level
  • CCEL $6.35
  • MDBH $5.50
  • Average True Range (ATR)
  • CCEL 0.26
  • MDBH 0.35
  • MACD
  • CCEL -0.03
  • MDBH 0.06
  • Stochastic Oscillator
  • CCEL 2.08
  • MDBH 50.19

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

Share on Social Networks: